Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
UBS
Argus Health
Mallinckrodt
AstraZeneca
Boehringer Ingelheim
McKesson
US Army
Chubb
Baxter

Generated: February 21, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 090316

« Back to Dashboard

NDA 090316 describes MIDOZALAM HYDROCHLORIDE, which is a drug marketed by Sagent Strides and is included in one NDA. It is available from one supplier. Additional details are available on the MIDOZALAM HYDROCHLORIDE profile page.

The generic ingredient in MIDOZALAM HYDROCHLORIDE is midazolam hydrochloride. There are nine drug master file entries for this compound. Twenty-three suppliers are listed for this compound. Additional details are available on the midazolam hydrochloride profile page.
Summary for 090316
Tradename:MIDOZALAM HYDROCHLORIDE
Applicant:Sagent Strides
Ingredient:midazolam hydrochloride
Patents:0
Formulation / Manufacturing:see details
Pharmacology for NDA: 090316
Ingredient-typeBenzodiazepines
Suppliers and Packaging for NDA: 090316
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
MIDOZALAM HYDROCHLORIDE midazolam hydrochloride INJECTABLE;INJECTION 090316 ANDA Sagent Pharmaceuticals 25021-660 N 25021-660-10
MIDOZALAM HYDROCHLORIDE midazolam hydrochloride INJECTABLE;INJECTION 090316 ANDA Sagent Pharmaceuticals 25021-661 N 25021-661-05

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrengthEQ 1MG BASE/ML
Approval Date:May 4, 2011TE:APRLD:No

Profile for product number 002

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrengthEQ 5MG BASE/ML
Approval Date:May 4, 2011TE:APRLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Medtronic
Healthtrust
Dow
Chinese Patent Office
McKesson
Citi
Queensland Health
Teva
Daiichi Sankyo

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot